Patent application number | Description | Published |
20090270389 | Pyrimidinyl pyridone inhibitors of kinases - This application discloses novel pyrimidinyl pyridone derivatives according to formula I, wherein A, R | 10-29-2009 |
20100004231 | INHIBITORS OF BURTON'S TYROSINE KINASE - This application discloses 5-phenyl-1H-pyrazin-2-one derivatives according to generic Formulae I-V: | 01-07-2010 |
20100016301 | Inhibitors of bruton's tyrosine kinase - This application discloses 6-Phenyl-imidazo[1,2-a]pyridine and 6-Phenyl-imidazo[1,2-b]pyridazine derivatives according to generic Formulae I-V: | 01-21-2010 |
20100016302 | Inhibitors of bruton's tyrosine kinase - This application discloses 6-Phenyl-imidazo[1,2-a]pyrazine derivatives according to generic Formulae I-V: | 01-21-2010 |
20100021423 | Heterocyclic antiviral compounds - Compounds having the formula I wherein R | 01-28-2010 |
20110059118 | INHIBITORS OF JAK - The present invention relates to the use of novel compounds of Formula I, | 03-10-2011 |
20130157998 | HETEROCYCLIC INHIBITORS OF GLUTAMINASE - The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention. | 06-20-2013 |
20140050699 | HETEROCYCLIC INHIBITORS OF GLUTAMINASE - The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention. | 02-20-2014 |
20140194421 | HETEROCYCLIC GLUTAMINASE INHIBITORS - The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention. | 07-10-2014 |
20150080393 | SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS - The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer. | 03-19-2015 |